[go: up one dir, main page]

AU4003497A - Therapeutic methods and compositions involving isoflavones - Google Patents

Therapeutic methods and compositions involving isoflavones

Info

Publication number
AU4003497A
AU4003497A AU40034/97A AU4003497A AU4003497A AU 4003497 A AU4003497 A AU 4003497A AU 40034/97 A AU40034/97 A AU 40034/97A AU 4003497 A AU4003497 A AU 4003497A AU 4003497 A AU4003497 A AU 4003497A
Authority
AU
Australia
Prior art keywords
therapeutic methods
compositions involving
isoflavones
involving isoflavones
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU40034/97A
Other versions
AU731951B2 (en
Inventor
George Eustace Joannou
Graham Edmund Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kazia Research Pty Ltd
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO2039A external-priority patent/AUPO203996A0/en
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Priority to AU40034/97A priority Critical patent/AU731951B2/en
Publication of AU4003497A publication Critical patent/AU4003497A/en
Priority to AU19723/01A priority patent/AU776894B2/en
Application granted granted Critical
Publication of AU731951B2 publication Critical patent/AU731951B2/en
Priority to AU2004224982A priority patent/AU2004224982B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU40034/97A 1996-08-30 1997-08-29 Therapeutic methods and compositions involving isoflavones Ceased AU731951B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU40034/97A AU731951B2 (en) 1996-08-30 1997-08-29 Therapeutic methods and compositions involving isoflavones
AU19723/01A AU776894B2 (en) 1996-08-30 2001-02-13 Therapeutic methods and compositions involving isoflavones
AU2004224982A AU2004224982B2 (en) 1996-08-30 2004-11-03 Therapeutic methods and compositions involving isoflavones

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPO2039A AUPO203996A0 (en) 1996-08-30 1996-08-30 Therapeutic uses
AUPO2039 1996-08-30
AU40034/97A AU731951B2 (en) 1996-08-30 1997-08-29 Therapeutic methods and compositions involving isoflavones
PCT/AU1997/000563 WO1998008503A1 (en) 1996-08-30 1997-08-29 Therapeutic methods and compositions involving isoflavones

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU19723/01A Division AU776894B2 (en) 1996-08-30 2001-02-13 Therapeutic methods and compositions involving isoflavones

Publications (2)

Publication Number Publication Date
AU4003497A true AU4003497A (en) 1998-03-19
AU731951B2 AU731951B2 (en) 2001-04-05

Family

ID=25624943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40034/97A Ceased AU731951B2 (en) 1996-08-30 1997-08-29 Therapeutic methods and compositions involving isoflavones

Country Status (1)

Country Link
AU (1) AU731951B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU750031C (en) * 1997-12-24 1999-08-02 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosuppression and skin damage
WO1999043335A1 (en) * 1998-02-25 1999-09-02 Novogen Research Pty. Ltd. Plant extracts and anti-cancer modalities involving the same
WO1999048496A1 (en) * 1998-03-26 1999-09-30 Novogen Research Pty. Ltd. Therapy of estrogen-associated disorders

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106017A (en) * 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd Anti-tumor agent
JPS62106016A (en) * 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd Immuno-suppressor
CA2136233C (en) * 1992-05-19 2004-03-30 Graham Edmund Kelly Health supplements containing phyto-oestrogens, analogues or metabolites thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU750031C (en) * 1997-12-24 1999-08-02 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosuppression and skin damage
AU750031B2 (en) * 1997-12-24 2002-07-11 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosuppression and skin damage
WO1999043335A1 (en) * 1998-02-25 1999-09-02 Novogen Research Pty. Ltd. Plant extracts and anti-cancer modalities involving the same
WO1999048496A1 (en) * 1998-03-26 1999-09-30 Novogen Research Pty. Ltd. Therapy of estrogen-associated disorders

Also Published As

Publication number Publication date
AU731951B2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
AU4479897A (en) Compositions including r-nsaids and therapeutic and prophylactic methods employing said compositions
AU6019898A (en) Devices for tissue repair and methods for preparation and use thereof
AU4907897A (en) Therapeutic liposome composition and method
AU5081298A (en) Surgical method and composition therefor
AU3890297A (en) Herbal formulation and therapeutic uses therefor
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU3767097A (en) Shampoo compositions and method
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU2226297A (en) Surgical model
AU3734597A (en) Human kallikrein
AU2349399A (en) R-lansoprazole compositions and methods
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU2972597A (en) Compositions and uses thereof
AU4215399A (en) Dermatological compositions and methods
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU3472799A (en) Dermatological formulations and methods
AU2670897A (en) Fibulin pharmaceutical compositions and related methods
AU2672795A (en) Benzopyrans and their use as therapeutic agents
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU5333298A (en) Compositions and methods for tumour therapy
AU3118297A (en) Sok-1 and methods of use
AU3200197A (en) New composition and methods
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AUPO982097A0 (en) Methods and compositions for use therein

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)